Modeling the Tertiary Structure of the Rift Valley Fever Virus L Protein.


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
07 May 2019
Historique:
received: 11 03 2019
revised: 13 04 2019
accepted: 03 05 2019
entrez: 10 5 2019
pubmed: 10 5 2019
medline: 29 8 2019
Statut: epublish

Résumé

A tertiary structure governs, to a great extent, the biological activity of a protein in the living cell and is consequently a central focus of numerous studies aiming to shed light on cellular processes central to human health. Here, we aim to elucidate the structure of the Rift Valley fever virus (RVFV) L protein using a combination of in silico techniques. Due to its large size and multiple domains, elucidation of the tertiary structure of the L protein has so far challenged both dry and wet laboratories. In this work, we leverage complementary perspectives and tools from the computational-molecular-biology and bioinformatics domains for constructing, refining, and evaluating several atomistic structural models of the L protein that are physically realistic. All computed models have very flexible termini of about 200 amino acids each, and a high proportion of helical regions. Properties such as potential energy, radius of gyration, hydrodynamics radius, flexibility coefficient, and solvent-accessible surface are reported. Structural characterization of the L protein enables our laboratories to better understand viral replication and transcription via further studies of L protein-mediated protein-protein interactions. While results presented a focus on the RVFV L protein, the following workflow is a more general modeling protocol for discovering the tertiary structure of multidomain proteins consisting of thousands of amino acids.

Identifiants

pubmed: 31067727
pii: molecules24091768
doi: 10.3390/molecules24091768
pmc: PMC6539450
pii:
doi:

Substances chimiques

RNA, Viral 0
Viral Proteins 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : George Mason University
ID : Multidisciplinary Research seed funds, Provost Office

Références

Biochemistry. 1999 Dec 14;38(50):16424-31
pubmed: 10600103
Biopolymers. 2000-2001;56(4):275-91
pubmed: 11754341
Protein Sci. 2002 Dec;11(12):2814-24
pubmed: 12441380
Bioinformatics. 2003 Mar 22;19(5):673-4
pubmed: 12651735
Bioinformatics. 2003 Oct;19 Suppl 2:ii246-55
pubmed: 14534198
Adv Protein Chem. 2003;66:27-85
pubmed: 14631816
Nat Struct Biol. 2003 Dec;10(12):980
pubmed: 14634627
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
J Comput Chem. 2004 Dec;25(16):2038-48
pubmed: 15481090
Antivir Chem Chemother. 2005;16(3):155-68
pubmed: 16004079
J Comput Chem. 2005 Dec;26(16):1668-88
pubmed: 16200636
Nucleic Acids Res. 2007 Jul;35(Web Server issue):W375-83
pubmed: 17452350
Science. 2008 Jun 13;320(5882):1429-30
pubmed: 18556537
J Theor Biol. 2009 Mar 7;257(1):17-26
pubmed: 19056401
J Virol. 2009 Dec;83(24):12779-89
pubmed: 19812169
Nat Protoc. 2010 Apr;5(4):725-38
pubmed: 20360767
Open Virol J. 2010 Apr 22;4:8-14
pubmed: 20517489
PLoS Pathog. 2010 Sep 16;6(9):e1001038
pubmed: 20862324
BMC Bioinformatics. 2011 Feb 01;12:43
pubmed: 21284866
Viruses. 2011 May;3(5):493-519
pubmed: 21666766
Proteins. 2011;79 Suppl 10:161-71
pubmed: 21987485
Adv Exp Med Biol. 2012;726:267-304
pubmed: 22297518
J Mol Biol. 1990 Oct 5;215(3):403-10
pubmed: 2231712
Curr Opin Virol. 2012 Jun;2(3):315-23
pubmed: 22463980
Biol Direct. 2012 Apr 17;7:12
pubmed: 22510480
Nucleic Acids Res. 2012 Jul;40(Web Server issue):W323-8
pubmed: 22564897
Nat Protoc. 2012 Jul 19;7(8):1511-22
pubmed: 22814390
Proteins. 2013 Jan;81(1):119-31
pubmed: 22927229
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W384-8
pubmed: 23737448
Bioinformatics. 2015 Jul 1;31(13):2098-105
pubmed: 25701568
Vaccine. 2015 Oct 13;33(42):5520-5531
pubmed: 26296499
J Chem Theory Comput. 2015 Aug 11;11(8):3696-713
pubmed: 26574453
Nucleic Acids Res. 2016 Jan 4;44(D1):D279-85
pubmed: 26673716
Curr Opin Struct Biol. 2016 Feb;36:75-84
pubmed: 26826467
Nucleic Acids Res. 2017 Jul 3;45(W1):W422-W428
pubmed: 28402475
Clin Lab Med. 2017 Jun;37(2):285-301
pubmed: 28457351
Nucleic Acids Res. 2017 Jul 3;45(W1):W400-W407
pubmed: 28498994
Bioinformatics. 2018 Mar 15;34(6):1063-1065
pubmed: 29126101
Future Virol. 2017 Nov;12(11):651-665
pubmed: 29181086
Viruses. 2018 Feb 10;10(2):
pubmed: 29439438
EMBO J. 1986 Apr;5(4):823-6
pubmed: 3709526
J Virol. 1984 Oct;52(1):215-22
pubmed: 6481853
J Gen Virol. 1994 Jun;75 ( Pt 6):1345-52
pubmed: 7515937
J Virol. 1995 Jul;69(7):3972-9
pubmed: 7769655
J Mol Graph. 1996 Feb;14(1):33-8, 27-8
pubmed: 8744570
Proc Natl Acad Sci U S A. 1998 May 26;95(11):5857-64
pubmed: 9600884

Auteurs

Gideon K Gogovi (GK)

Center for Simulation and Modeling, George Mason University, 4400 University Drive, MSN 6A12, Fairfax, VA 22030, USA. ggogovi@masonlive.gmu.edu.
Department of Computational and Data Sciences, George Mason University, 4400 University Drive, MSN 6A12, Fairfax, VA 22030, USA. ggogovi@masonlive.gmu.edu.

Fahad Almsned (F)

School of Systems Biology, George Mason University, 10900 University Blvd., MSN 5B3, Manassas, VA 20110, USA. falmsned@masonlive.gmu.edu.

Nicole Bracci (N)

School of Systems Biology, George Mason University, 10900 University Blvd., MSN 5B3, Manassas, VA 20110, USA. nbracci@masonlive.gmu.edu.
National Center for Biodefense and Infectious Diseases, George Mason University, 10650 Pyramid Place, MS 1J5, Manassas, VA 20110, USA. nbracci@masonlive.gmu.edu.

Kylene Kehn-Hall (K)

School of Systems Biology, George Mason University, 10900 University Blvd., MSN 5B3, Manassas, VA 20110, USA. kkehnhal@gmu.edu.
National Center for Biodefense and Infectious Diseases, George Mason University, 10650 Pyramid Place, MS 1J5, Manassas, VA 20110, USA. kkehnhal@gmu.edu.

Amarda Shehu (A)

Center for Simulation and Modeling, George Mason University, 4400 University Drive, MSN 6A12, Fairfax, VA 22030, USA. ashehu@gmu.edu.
School of Systems Biology, George Mason University, 10900 University Blvd., MSN 5B3, Manassas, VA 20110, USA. ashehu@gmu.edu.
Department of Computer Science, George Mason University, 4400 University Drive, MSN 4A5, Fairfax, VA 22030, USA. ashehu@gmu.edu.
Department of Bioengineering, George Mason University, 4400 University Drive, MSN 1J7, Fairfax, VA 22030, USA. ashehu@gmu.edu.

Estela Blaisten-Barojas (E)

Center for Simulation and Modeling, George Mason University, 4400 University Drive, MSN 6A12, Fairfax, VA 22030, USA. blaisten@gmu.edu.
Department of Computational and Data Sciences, George Mason University, 4400 University Drive, MSN 6A12, Fairfax, VA 22030, USA. blaisten@gmu.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH